Skip to main content
. 2019 May 6;18(1):465–471. doi: 10.3892/ol.2019.10318

Table II.

MSRB3 expression and clinical characteristics of 90 patients with gastric cancer.

MSRB3 expression

Variable Cases, n Low High P-value
Age, years 0.731
  <65 39 12 27
  ≥65 51 14 37
Sex 0.901
  Female 20 6 14
  Male 70 20 50
Maximum tumor diameter, cm 0.850
  <5 30 9 21
  ≥5 57 16 41
Histological differentiation 0.972
  Moderate-high 24 7 17
  Poor 66 19 47
Depth of invasion 0.403
  T1-2 11 2 9
  T3-4 79 24 55
Lymph node metastasis 0.850
  N0 23 7 16
  N+ 67 19 48
Distant metastasis 0.697
  M0 86 24 62
  M1 4 2 2
TNM stage 0.745
  I/II 37 10 27
  III/IV 53 16 37

MSRB3, methionine sulfoxide reductases B3; TNM, Tumor-Node-Metastasis; GC, gastric cancer.